(4) Li JJ, Sun WD, Zhu XJ, Mei YZ, Li WS, Li JH
alternative protocols (e.g., 100 mcg every other day) may be selected based on clinical response and laboratory indices
Patients with severe hepatic or renal impairment may require special consideration, though specific dosing guidelines for these populations have not been established
Some models report measurable pathway changes within days, while others require longer observation periods
This solution is intended only as a diluent or solvent for the preparation of medications for intravenous, intramuscular, or subcutaneous injection , according to the specific instructions provided by the drug manufacturer
Every study used the stable gastric pentadecapeptide form of BPC-157 (the same form available commercially)